{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:26:34Z","timestamp":1789453594776,"version":"build-2803163510"},"reference-count":18,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":30,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1002\/pds.3842","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T03:46:56Z","timestamp":1438573616000},"page":"1042-1048","source":"Crossref","is-referenced-by-count":21,"title":["Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia"],"prefix":"10.1002","volume":"24","author":[{"given":"Lee Hilary","family":"Goldstein","sequence":"first","affiliation":[{"name":"Department of Internal Medicine C; Ha'emek Medical Center; Afula Israel"},{"name":"Bruce Rappaport Faculty of Medicine; Technion-Israel Institute of Technology; Haifa Israel"},{"name":"Clinical Pharmacology Unit; Ha'emek Medical Center; Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Gabin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine C; Ha'emek Medical Center; Afula Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Fawaz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine C; Ha'emek Medical Center; Afula Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahum Adam","family":"Freedberg","sequence":"additional","affiliation":[{"name":"Bruce Rappaport Faculty of Medicine; Technion-Israel Institute of Technology; Haifa Israel"},{"name":"Department of Cardiology and Electrophysiology Unit; Ha'emek Medical Center; Afula Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Clinical Research Unit; Ha'emek Medical Center; Afula Israel"},{"name":"School of public health; University of Haifa; Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Elias","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine C; Ha'emek Medical Center; Afula Israel"},{"name":"Bruce Rappaport Faculty of Medicine; Technion-Israel Institute of Technology; Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Saliba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine C; Ha'emek Medical Center; Afula Israel"},{"name":"Bruce Rappaport Faculty of Medicine; Technion-Israel Institute of Technology; Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,2]]},"reference":[{"key":"10.1002\/pds.3842-BIB0001|pds3842-cit-0001","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1128\/AAC.44.10.2630-2637.2000","article-title":"Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats","volume":"44","author":"Ohatani","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/pds.3842-BIB0002|pds3842-cit-0002","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/pmj.76.900.651","article-title":"QT prolongation due to roxithromycin","volume":"76","author":"Woywodt","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1002\/pds.3842-BIB0003|pds3842-cit-0003","first-page":"U666","article-title":"A case of QT-interval prolongation precipitated by azithromycin","volume":"116","author":"Matsunaga","year":"2003","journal-title":"N Z Med J"},{"key":"10.1002\/pds.3842-BIB0004|pds3842-cit-0004","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1046\/j.1460-9592.2001.01572.x","article-title":"QT prolongation associated with azithromycin\/amiodarone combination","volume":"24","author":"Samarendra","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1002\/pds.3842-BIB0005|pds3842-cit-0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10840-007-9124-y","article-title":"Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors","volume":"18","author":"Kezerashvili","year":"2007","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1002\/pds.3842-BIB0006|pds3842-cit-0006","first-page":"30","article-title":"Azithromycin-induced QT prolongation in elderly patient","volume":"77","author":"Russo","year":"2006","journal-title":"Acta Biomed"},{"key":"10.1002\/pds.3842-BIB0007|pds3842-cit-0007","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0002-8703(96)90258-6","article-title":"Erythromycin-induced polymorphous ventricular tachycardia with normal QT interval","volume":"132","author":"Chennareddy","year":"1996","journal-title":"Am Heart J"},{"key":"10.1002\/pds.3842-BIB0008|pds3842-cit-0008","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3842-BIB0009|pds3842-cit-0009","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1300799","article-title":"Use of azithromycin and death from cardiovascular causes","volume":"368","author":"Svanstr\u00f6m","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3842-BIB0010|pds3842-cit-0010","unstructured":"FDA Statement regarding azithromycin (Zithromax) and the risk of cardiovascular death 2012 http:\/\/www.fda.gov\/Drugs\/Drugsafety\/ucm304372.htm"},{"key":"10.1002\/pds.3842-BIB0011|pds3842-cit-0011","unstructured":"FDA Drug Safety Communication: azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms 2013 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm341822.htm"},{"key":"10.1002\/pds.3842-BIB0012|pds3842-cit-0012","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2014.4304","article-title":"Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia","volume":"311","author":"Mortensen","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/pds.3842-BIB0013|pds3842-cit-0013","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3842-BIB0014|pds3842-cit-0014","first-page":"355","article-title":"An analysis of the time relationships of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1002\/pds.3842-BIB0015|pds3842-cit-0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QCO.0000000000000055","article-title":"Cardiac diseases complicating community-acquired pneumonia","volume":"27","author":"Aliberti","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1002\/pds.3842-BIB0016|pds3842-cit-0016","doi-asserted-by":"crossref","first-page":"e1001048","DOI":"10.1371\/journal.pmed.1001048","article-title":"Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies","volume":"8","author":"Corrales-Medina","year":"2011","journal-title":"PLoS Med"},{"key":"10.1002\/pds.3842-BIB0017|pds3842-cit-0017","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.111.040766","article-title":"Cardiac complications in patients with community-acquired pneumonia. Incidence, timing, risk factors, and association with short-term mortality","volume":"125","author":"Corrales-Medina","year":"2012","journal-title":"Circulation"},{"key":"10.1002\/pds.3842-BIB0018|pds3842-cit-0018","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1445-5994.2011.02447.x","article-title":"Prevalence and determinants of QT interval prolongation in medical inpatients","volume":"42","author":"Pasquier","year":"2012","journal-title":"Internal Med J"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3842","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.3842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T02:07:17Z","timestamp":1533521237000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pds.3842"}},"subtitle":["Azithromycin and QT prolongation"],"short-title":[],"issued":{"date-parts":[[2015,8,2]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3842","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,2]]}}}